Investor Presentation

AI summary - Q1FY27 revenue INR 25,804 Mn +22.8% y-y; EBITDA INR 5,080 Mn +25.8% y-y; PAT INR 2,925 Mn +36.2% y-y - International business revenue up 34.2% y-y, contributing 58% of total revenue - Domestic revenue grew 10.2% y-y, led by CNS, women’s health, and cardio-metabolics - EBITDA margin improved 50 bps to 19.7%; PAT margin up 110 bps to 11.3% - R&D spend increased, supporting pipeline and product approvals - Net debt to EBITDA at 0.6x; RoCE steady at 3.5% - Leadership changes: Satish Mehta to become Chairman; Samit Mehta appointed COO - Strong growth outlook supported by new product launches and geographic expansion